Compare Orion Oyj with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
5.9%
0%
5.9%
6 Months
5.57%
0%
5.57%
1 Year
25.79%
0%
25.79%
2 Years
95.19%
0%
95.19%
3 Years
65.28%
0%
65.28%
4 Years
67.7%
0%
67.7%
5 Years
98.41%
0%
98.41%
Orion Oyj for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
11.88%
EBIT Growth (5y)
17.93%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0.11
Net Debt to Equity (avg)
0.06
Sales to Capital Employed (avg)
1.24
Tax Ratio
20.16%
Dividend Payout Ratio
50.61%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
40.73%
ROE (avg)
29.77%
Valuation key factors
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
7.63
EV to EBIT
15.85
EV to EBITDA
14.54
EV to Capital Employed
7.00
EV to Sales
5.26
PEG Ratio
0.39
Dividend Yield
NA
ROCE (Latest)
44.15%
ROE (Latest)
38.95%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Bullish
OBV
Mildly Bearish
Bullish
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
695.30
422.70
64.49%
Operating Profit (PBDIT) excl Other Income
342.30
133.40
156.60%
Interest
1.10
0.60
83.33%
Exceptional Items
0.00
0.00
Consolidate Net Profit
260.50
96.00
171.35%
Operating Profit Margin (Excl OI)
470.90%
282.20%
18.87%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 64.49% vs 1.42% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 171.35% vs 16.36% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,887.80
1,541.40
22.47%
Operating Profit (PBDIT) excl Other Income
681.30
498.70
36.62%
Interest
8.70
8.40
3.57%
Exceptional Items
-0.40
-38.00
98.95%
Consolidate Net Profit
500.30
329.90
51.65%
Operating Profit Margin (Excl OI)
331.10%
290.20%
4.09%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 22.47% vs 29.39% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 51.65% vs 52.17% in Dec 2024
About Orion Oyj 
Orion Oyj
Pharmaceuticals & Biotechnology
Orion Oyj, previously Orion Corporation, is a Finland-based company active within the pharmaceutical industry. The Company is engaged in the research and development, manufacture and marketing of human and veterinary pharmaceuticals and active pharmaceutical ingredients. The core therapy areas of the Company's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases.
Company Coordinates 
Company Details
Orionintie 1A , ESPOO None : 02200
Registrar Details






